Atherectomy Devices Market to Reach an Opportunity of US$ 735 Mn by the End of 2022

Atherectomy Devices Market: Overview

The world atherectomy devices market has been prophesized to gain momentum owing to the soaring cases of peripheral artery diseases or PAD as it is conveniently called worldwide. It has been estimated that more than 250 million people have been affected with peripheral artery diseases across the globe. Over the time period that extends from 2000 to 2010, the occurrence of peripheral artery diseases increased by 24% and is expected to rise at a substantially high rate, resulting in an astounding growth in the adoption of atherectomy devices.

Furthermore, the procedure of atherectomy is minimally invasive and phenomenal rise in the increasing preference for such minimally invasive procedures is, in all likelihood, to bolster the world market for atherectomy devices.

The market for atherectomy devices is forecasted to reach US$558.9 mn towards the end of the year 2017. The market is expected to register a CAGR of 5.60% over the forecast timeframe that extends from the year 2017 to 2022 and the same is expected to obtain a market value of US$735 mn by the year 2022.

Taking vendor landscape into consideration, the market for atherectomy device can be regarded as significantly fragmented and the market players emphasize on strategically important acquisitions, mergers, collaborations and partnerships in a bid to strengthen their hold on the market.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Atherectomy Device Market: Trends and Opportunities

For the treatment of various peripheral, neurovascular, and cardiovascular diseases, atherectomy devices are mainly used. Ambulatory surgical centers or ASCs as it is conveniently called, clinics, and hospitals mostly make optimum use of atherectomy devices. More specifically, hospitals across the globe have been generating much higher demand for the said devices. Apart from the hospitals, it’s also the categories of ASCs and clinics that are forecasted to register a robust growth as a result of the increased adoption of these atherectomy devices in the coming years.

As noticed by the TMR analysts, increasing occurrences of peripheral artery diseases worldwide is prognosticated to boost the world atherectomy devices market. Furthermore, substantial expansion of the geriatric population across the globe has significantly increased the number of people who have been affected with peripheral artery diseases. This has eventually bolstered the demand for the said devices worldwide. It is also forecasted that the said market is expected to benefit significantly in the forthcoming years from the increasing preference of minimally invasive procedures of surgery.

Laser devices, orbital devices, rotational device, and directional devices all have emerged as the prominent atherectomy devices worldwide. The directional devices have been leading the world market owing to high market penetration and early inception.

Atherectomy device Market: Geography

The market research report also comes with geographical segmentations and analysis of the world market for atherectomy devices market. In accordance with the said study, the market extends across the regions of Japan, the Middle East and Africa (MEA), North America, Europe, and Asia Pacific excluding Japan (APEJ). Of all of these regions, North America has emerged as the one of the most dominating zones for the global atherectomy devices market. Availability of encouraging reimbursement facilities has further assisted the North American market significantly in the last few years.

Each and every regional classification has been thoroughly studied in this research publication with an aim to make an offering of a comprehensive, well-informed assessment of the market performance in various different geographies across the globe.

Atherectomy device Market: Company Profiling

The vendor landscape of this market for atherectomy devices is quite competitive and the same is foreseen to become more intense in the forthcoming years. The authors of this report have profiled some of the topnotch companies that are active in this market. Companies such as Cardiovascular Systems Inc., Medtronic Plc., Royal Philips NV, Avinger Inc., Boston Scientific Corp., Terumo Corp., and Spectranetics Corp. are some of the eminent vendors that adorn the global market for atherectomy devices.